State Street’s Nymox Pharmaceutical Corp NYMX Stock Holding History

State Street’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,494	Closed	-$48K	–	4717
2021 Q2	$48K	Sell	30,494 -624,899	-95%	-$1.16M	﹤0.01%	4431
2021 Q1	$1.46M	Buy	655,393 +50,378	+8%	+$133K	﹤0.01%	3542
2020 Q4	$1.5M	Buy	605,015 +108,894	+22%	+$241K	﹤0.01%	3466
2020 Q3	$1.22M	Buy	496,121 +74,138	+18%	+$216K	﹤0.01%	3381
2020 Q2	$1.5M	Buy	+421,983	New	+$1.33M	﹤0.01%	3292
2019 Q3	–	Sell	-23,677	Closed	-$34K	–	3826
2019 Q2	$34K	Sell	23,677 -461,907	-95%	-$808K	﹤0.01%	3748
2019 Q1	$957K	Buy	485,584 +18,837	+4%	+$40K	﹤0.01%	3347
2018 Q4	$611K	Sell	466,747 -13,616	-3%	-$24.9K	﹤0.01%	3417
2018 Q3	$1.18M	Buy	480,363 +4,129	+0.9%	+$12.2K	﹤0.01%	3378
2018 Q2	$1.6M	Buy	476,234 +20,621	+5%	+$79.3K	﹤0.01%	3332
2018 Q1	$1.93M	Buy	455,613 +74,031	+19%	+$257K	﹤0.01%	3183
2017 Q4	$1.26M	Buy	381,582 +55,695	+17%	+$203K	﹤0.01%	3311
2017 Q3	$1.25M	Buy	325,887 +25,024	+8%	+$94.9K	﹤0.01%	3332
2017 Q2	$1.32M	Buy	+300,863	New	+$1.24M	﹤0.01%	3274

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street's NYMX Position: Q3 2021 in Review

State Street sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2021, closing a stake of 30,494 shares — an estimated $48K sold.

State Street first reported a position in NYMX in Q2 2017 and held it in 14 quarters. The position peaked at $1.93M in Q1 2018. 38 funds tracked by Wall St. Rank hold NYMX as of Q3 2021.

State Street reported no remaining Nymox Pharmaceutical Corp position as of Q3 2021 after selling out during the quarter.
State Street sold 30,494 Nymox Pharmaceutical Corp shares in Q3 2021, an estimated $48K.
State Street first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 14 quarters.
State Street's Nymox Pharmaceutical Corp position peaked at $1.93M in Q1 2018.
38 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2021.

Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.